Pilocarpine Hydrochloride + Timolol MaleateThird Party Manufacturing in India

Pilocarpine Hydrochloride + Timolol Maleate works by using two distinct pathways to achieve a synergistic drop in intraocular pressure. Pilocarpine Hydrochloride stimulates muscarinic receptors to contract the ciliary muscle, widening the trabecular meshwork and increasing aqueous humor outflow. Timolol Maleate concurrently blocks beta-receptors to decrease the production of the very same fluid. Unlike single-agent therapies, it attacks the hydrodynamic imbalance from both the supply and drainage sides. It is highly effective and well-tolerated.

Therapeutic Uses

• Refractory Open-Angle Glaucoma: Manages intraocular pressure in patients who do not achieve therapeutic targets with mono-therapy.
• Acute Angle-Closure Glaucoma: Aids in emergency reduction of intraocular pressure prior to definitive surgical intervention.

Why Manufacturers Choose Pilocarpine Hydrochloride + Timolol Maleate

This dual-action formula is vital for aggressive glaucoma management, driving sustained B2B demand among ophthalmologists. Sourcing through Pilocarpine Hydrochloride + Timolol Maleate third party manufacturing in India ensures compliance with complex stabilization protocols required for mixing a cholinergic agonist and a beta-blocker. Our production facilities are WHO-GMP certified, managing strict quality controls for both actives under primary CAS number 54-71-7 to produce an optimal prescription-grade product.